The top documents tagged [human monoclonal antibody]

Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in Hyperlipidemic Subjects: A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled
Documents Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in Hyperlipidemic Subjects: A 52 Week Phase 3 Double-blind, Randomized, Placebo-controlled

218 views

Safety and Efficacy of Denosumab for Giant Cell Tumor of Bone Jean-Yves Blay 1 ; Sant Chawla 2 ; Leanne Seeger 3 ; Robert Henshaw 4 ; Edwin Choy 5 ; Robert
Documents Safety and Efficacy of Denosumab for Giant Cell Tumor of Bone Jean-Yves Blay 1 ; Sant Chawla 2 ; Leanne Seeger 3 ; Robert Henshaw 4 ; Edwin Choy 5 ; Robert

215 views

Cell culture 03
Technology Cell culture 03

310 views

UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL
Education UPDATE ON THE PCKS9 INHIBITION TO LOWER LDL CHOLESTEROL

500 views

Immunogenicity of different stressed igG monoclonal antibody formulations
Education Immunogenicity of different stressed igG monoclonal antibody formulations

25 views

Denosumab safety and efficacy in giant cell tumor of bone (GCTB): Interim results from a phase 2 study Jean-Yves Blay 1, Sant Chawla 2, Javier Martin Broto
Documents Denosumab safety and efficacy in giant cell tumor of bone (GCTB): Interim results from a phase 2 study Jean-Yves Blay 1, Sant Chawla 2, Javier Martin Broto

219 views

Humblet ASCO 2007 – Draft CONFIDENTIAL Association of skin toxicity (ST) severity with clinical outcomes and health-related quality of life (HRQoL) with
Documents Humblet ASCO 2007 – Draft CONFIDENTIAL Association of skin toxicity (ST) severity with clinical outcomes and health-related quality of life (HRQoL) with

216 views

For Advisors Only BIOLOGIC THERAPY IN CROHN’S DISEASE ATILLA ERTAN, FACP, AGAF, MACG
Documents For Advisors Only BIOLOGIC THERAPY IN CROHN’S DISEASE ATILLA ERTAN, FACP, AGAF, MACG

221 views

Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145: 52-Week Results From the OSLER Study Michael J
Documents Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145: 52-Week Results From the OSLER Study Michael J

227 views

Cause of disability. Changes in the joint inflammation, proliferation of the synovium, errosion of cartilage & bones
Documents Cause of disability. Changes in the joint inflammation, proliferation of the synovium, errosion of cartilage & bones

216 views

Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects (GAUSS): Results from a Randomized, Double-blind, Placebo- Controlled
Documents Goal Achievement after Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects (GAUSS): Results from a Randomized, Double-blind, Placebo- Controlled

216 views

GICS 2012 Final skin toxicity and patient ‑ reported outcomes results from PRIME: A randomized phase 3 study of panitumumab + FOLFOX4 for 1 st ‑ line metastatic
Documents GICS 2012 Final skin toxicity and patient ‑ reported outcomes results from PRIME: A randomized phase 3 study of panitumumab + FOLFOX4 for 1 st ‑ line metastatic

214 views